[1]
Neal JM, Barrington MJ, Fettiplace MR, Gitman M, Memtsoudis SG, Mörwald EE, Rubin DS, Weinberg G. The Third American Society of Regional Anesthesia and Pain Medicine Practice Advisory on Local Anesthetic Systemic Toxicity: Executive Summary 2017. Regional anesthesia and pain medicine. 2018 Feb:43(2):113-123. doi: 10.1097/AAP.0000000000000720. Epub
[PubMed PMID: 29356773]
[2]
Lavonas EJ, Drennan IR, Gabrielli A, Heffner AC, Hoyte CO, Orkin AM, Sawyer KN, Donnino MW. Part 10: Special Circumstances of Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015 Nov 3:132(18 Suppl 2):S501-18. doi: 10.1161/CIR.0000000000000264. Epub
[PubMed PMID: 26472998]
[3]
Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998 Apr:88(4):1071-5
[PubMed PMID: 9579517]
[4]
Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Regional anesthesia and pain medicine. 2003 May-Jun:28(3):198-202
[PubMed PMID: 12772136]
[5]
Cave G, Harvey MG, Winterbottom T. Evaluation of the Association of Anaesthetists of Great Britain and Ireland lipid infusion protocol in bupivacaine induced cardiac arrest in rabbits. Anaesthesia. 2009 Jul:64(7):732-7. doi: 10.1111/j.1365-2044.2009.05893.x. Epub
[PubMed PMID: 19624627]
[6]
Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006 Jul:105(1):217-8
[PubMed PMID: 16810015]
[7]
Aditya A, Amar P, Chander A, Goel N, Jain K, Samra T. Ropivacaine induced systemic toxicity in a patient with phacomatosis pigmentokeratotica. Indian journal of pharmacology. 2021 Mar-Apr:53(2):153-156. doi: 10.4103/ijp.IJP_521_20. Epub
[PubMed PMID: 34100399]
[8]
Esen M, Uysal M. Protective effects of intravenous lipid emulsion on malathion-induced hepatotoxicity. Bratislavske lekarske listy. 2018:119(6):373-378. doi: 10.4149/BLL_2018_069. Epub
[PubMed PMID: 29947238]
[9]
Gosselin S, Hoegberg LC, Hoffman RS, Graudins A, Stork CM, Thomas SH, Stellpflug SJ, Hayes BD, Levine M, Morris M, Nesbitt-Miller A, Turgeon AF, Bailey B, Calello DP, Chuang R, Bania TC, Mégarbane B, Bhalla A, Lavergne V. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning(). Clinical toxicology (Philadelphia, Pa.). 2016 Dec:54(10):899-923. doi: 10.1080/15563650.2016.1214275. Epub 2016 Sep 8
[PubMed PMID: 27608281]
[10]
Purg D, Markota A, Grenc D, Sinkovič A. Low-dose intravenous lipid emulsion for the treatment of severe quetiapine and citalopram poisoning. Arhiv za higijenu rada i toksikologiju. 2016 Jun 1:67(2):164-6. doi: 10.1515/aiht-2016-67-2802. Epub
[PubMed PMID: 27331303]
[11]
Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: a systematic review. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2009 Sep:16(9):815-24. doi: 10.1111/j.1553-2712.2009.00499.x. Epub
[PubMed PMID: 19845549]
Level 1 (high-level) evidence
[12]
American College of Medical Toxicology. ACMT Position Statement: Guidance for the Use of Intravenous Lipid Emulsion. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2017 Mar:13(1):124-125. doi: 10.1007/s13181-016-0550-z. Epub 2016 Apr 27
[PubMed PMID: 27121236]
[13]
Fettiplace MR, Weinberg G. The Mechanisms Underlying Lipid Resuscitation Therapy. Regional anesthesia and pain medicine. 2018 Feb:43(2):138-149. doi: 10.1097/AAP.0000000000000719. Epub
[PubMed PMID: 29356774]
[14]
Ok SH, Hong JM, Lee SH, Sohn JT. Lipid Emulsion for Treating Local Anesthetic Systemic Toxicity. International journal of medical sciences. 2018:15(7):713-722. doi: 10.7150/ijms.22643. Epub 2018 May 14
[PubMed PMID: 29910676]
[15]
Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. The American journal of clinical nutrition. 2007 May:85(5):1171-84
[PubMed PMID: 17490951]
[16]
Raman M, Almutairdi A, Mulesa L, Alberda C, Beattie C, Gramlich L. Parenteral Nutrition and Lipids. Nutrients. 2017 Apr 14:9(4):. doi: 10.3390/nu9040388. Epub 2017 Apr 14
[PubMed PMID: 28420095]
[17]
Tang W, Wang Q, Shi K, Dong J, Lin S, Zhao S, Wu C, Xia Y, Papadimos TJ, Xu X. The Effect of Lipid Emulsion on Pharmacokinetics of Bupivacaine in Rats: Long-Chain Triglyceride Versus Long- and Medium-Chain Triglyceride. Anesthesia and analgesia. 2016 Nov:123(5):1116-1122
[PubMed PMID: 27224931]
[18]
Yilmaz M, Celebi H, Akcali D, Gurel N. Pre-treatment of bupivacaine-induced cardiovascular depression using different lipid formulations of propofol. Acta anaesthesiologica Scandinavica. 2014 Mar:58(3):298-302. doi: 10.1111/aas.12263. Epub 2014 Jan 20
[PubMed PMID: 24438483]
[19]
Neal JM, Neal EJ, Weinberg GL. American Society of Regional Anesthesia and Pain Medicine Local Anesthetic Systemic Toxicity checklist: 2020 version. Regional anesthesia and pain medicine. 2021 Jan:46(1):81-82. doi: 10.1136/rapm-2020-101986. Epub 2020 Nov 4
[PubMed PMID: 33148630]
[20]
Hayes BD, Gosselin S, Calello DP, Nacca N, Rollins CJ, Abourbih D, Morris M, Nesbitt-Miller A, Morais JA, Lavergne V, Lipid Emulsion Workgroup. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clinical toxicology (Philadelphia, Pa.). 2016 Jun:54(5):365-404. doi: 10.3109/15563650.2016.1151528. Epub 2016 Apr 1
[PubMed PMID: 27035513]
Level 1 (high-level) evidence
[21]
Levine M, Skolnik AB, Ruha AM, Bosak A, Menke N, Pizon AF. Complications following antidotal use of intravenous lipid emulsion therapy. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2014 Mar:10(1):10-4. doi: 10.1007/s13181-013-0356-1. Epub
[PubMed PMID: 24338451]
[22]
Rodríguez B, Wilhelm A, Kokko KE. Lipid emulsion use precluding renal replacement therapy. The Journal of emergency medicine. 2014 Dec:47(6):635-7. doi: 10.1016/j.jemermed.2014.07.040. Epub 2014 Sep 27
[PubMed PMID: 25271183]
[23]
Hiller DB, Gregorio GD, Ripper R, Kelly K, Massad M, Edelman L, Edelman G, Feinstein DL, Weinberg GL. Epinephrine impairs lipid resuscitation from bupivacaine overdose: a threshold effect. Anesthesiology. 2009 Sep:111(3):498-505. doi: 10.1097/ALN.0b013e3181afde0a. Epub
[PubMed PMID: 19704251]
[24]
Pichler J, Biassoni L, Easty M, Irastorza I, Hill S. Reduced risk of pulmonary emboli in children treated with long-term parenteral nutrition. Clinical nutrition (Edinburgh, Scotland). 2016 Dec:35(6):1406-1413. doi: 10.1016/j.clnu.2016.03.016. Epub 2016 Mar 31
[PubMed PMID: 27086197]
[25]
Petersen KM, Jørgensen NR, Bøgevig S, Petersen TS, Jensen TB, Dalhoff KP, Christensen MB. Effects of high-dose, intravenous lipid emulsion on laboratory tests in humans: a randomized, placebo-controlled, double-blind, clinical crossover trial. Clinical chemistry and laboratory medicine. 2018 Nov 27:56(12):2047-2057. doi: 10.1515/cclm-2018-0430. Epub
[PubMed PMID: 30004900]
Level 1 (high-level) evidence
[26]
Grunbaum AM, Gilfix BM, Gosselin S, Blank DW. Analytical interferences resulting from intravenous lipid emulsion. Clinical toxicology (Philadelphia, Pa.). 2012 Nov:50(9):812-7. doi: 10.3109/15563650.2012.731509. Epub
[PubMed PMID: 23075253]
[27]
Grunbaum AM, Gilfix BM, Hoffman RS, Lavergne V, Morris M, Miller-Nesbitt A, Gosselin S. Review of the effect of intravenous lipid emulsion on laboratory analyses. Clinical toxicology (Philadelphia, Pa.). 2016:54(2):92-102. doi: 10.3109/15563650.2015.1115515. Epub 2015 Dec 1
[PubMed PMID: 26623668]
[28]
Johnson-Arbor K, Salinger L, Luczycki S. Prolonged Laboratory Interference After Administration of Intravenous Lipid Emulsion Therapy. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2015 Jun:11(2):223-6. doi: 10.1007/s13181-014-0438-8. Epub
[PubMed PMID: 25298244]
[29]
Solé-Enrech G, Cano-Corres R, Aparicio-Calvente MI, Spataro N. Elimination of lipaemic interference by high-speed centrifugation. Biochemia medica. 2023 Feb 15:33(1):010703. doi: 10.11613/BM.2023.010703. Epub 2022 Dec 15
[PubMed PMID: 36627977]
[30]
Spray JW. Review of Intravenous Lipid Emulsion Therapy. Journal of infusion nursing : the official publication of the Infusion Nurses Society. 2016 Nov/Dec:39(6):377-380
[PubMed PMID: 27828934]
[31]
Lunn M, Fausnight T. Hypersensitivity to total parenteral nutrition fat-emulsion component in an egg-allergic child. Pediatrics. 2011 Oct:128(4):e1025-8. doi: 10.1542/peds.2010-2771. Epub 2011 Sep 12
[PubMed PMID: 21911353]
[32]
Mirtallo JM, Ayers P, Boullata J, Gura KM, Plogsted S, Anderson CR, Worthington P, Seres DS, Nicolai E, Alsharhan M, Gutsul L, Mason AE. ASPEN Lipid Injectable Emulsion Safety Recommendations, Part 1: Background and Adult Considerations. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2020 Oct:35(5):769-782. doi: 10.1002/ncp.10496. Epub 2020 May 27
[PubMed PMID: 32460429]
[33]
Senthilkumaran S, Menezes RG, Jayaraman S, Thirumalaikolundusubramanian P. Intralipid in lipophilic drug over dose: Dissecting fact from fiction. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2014 Jun:18(6):405. doi: 10.4103/0972-5229.133943. Epub
[PubMed PMID: 24987243]
[34]
Haber LM, Hawkins EP, Seilheimer DK, Saleem A. Fat overload syndrome. An autopsy study with evaluation of the coagulopathy. American journal of clinical pathology. 1988 Aug:90(2):223-7
[PubMed PMID: 3394663]
[35]
Corwin DJ, Topjian A, Banwell BL, Osterhoudt K. Adverse events associated with a large dose of intravenous lipid emulsion for suspected local anesthetic toxicity. Clinical toxicology (Philadelphia, Pa.). 2017 Jul:55(6):603-607. doi: 10.1080/15563650.2017.1294693. Epub 2017 Feb 26
[PubMed PMID: 28489457]